Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/9552069/ below:

Comorbidity and functional status are independent in older cancer patients

Comparative Study

Affiliations

• ¹ Senior Adult Oncology Program, H. Lee Moffitt Cancer and Research Institute, University of South Florida, Tampa 33612, USA. extermann@moffitt.usf.edu

• PMID: 9552069
• DOI: 10.1200/JCO.1998.16.4.1582

Item in Clipboard

Comparative Study

M Extermann et al. J Clin Oncol. 1998 Apr.

• ¹ Senior Adult Oncology Program, H. Lee Moffitt Cancer and Research Institute, University of South Florida, Tampa 33612, USA. extermann@moffitt.usf.edu

• PMID: 9552069
• DOI: 10.1200/JCO.1998.16.4.1582

Item in Clipboard

Purpose: Comorbidity is a frequent and often therapeutically limiting problem in older cancer patients. However, to date, there is no standard measure of the comorbidity burden available for these patients. We tested the performance of two comorbidity scales and their relationship with functional status.

Patients and methods: The Cumulative Illness Rating Scale-Geriatric (CIRS-G) was compared with the Charlson scale in 203 patients who received a comprehensive geriatric assessment (CGA) in our Senior Adult Oncology Program (SAOP). Study end points were variability, reliability, correlation with Eastern Cooperative Oncology Group (ECOG) performance status (PS), Activities of Daily Living (ADL), and Instrumental Activities of Daily Living (IADL). The relative weight of comorbidity versus tumor stage in the correlations with functional status was assessed.

Results: Median age was 75 years (range, 63 to 91). Sixty-four percent of patients scored 0 on the Charlson scale versus 6% on the CIRS-G. The correlation between the Charlson and CIRS-G was fair (p = 0.25 to 0.39). CIRS-G grade 3/4 had a fair correlation with ADL (p = 0.27). Otherwise, there was low or no correlation between comorbidity and functional status across the measures. Tumor stage was not correlated with functional status either. Correlation of ECOG PS with ADL (p = 0.51)c and IADL (p = 0.61) was moderate. Interrater and test-retest correlations were good or very good for both the Charlson and CIRS-G.

Conclusion: Comorbidity needs to be assessed independently from functional status. Both the Charlson and CIRS-G scales are reliable tools for use in trials of older cancer patients. Both can be tested in further studies as predictors of outcomes such as toxicity of treatment, changes in functional status, or survival.

PubMed Disclaimer

• Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study.

  Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V. Repetto L, et al. J Clin Oncol. 2002 Jan 15;20(2):494-502. doi: 10.1200/JCO.2002.20.2.494. J Clin Oncol. 2002. PMID: 11786579

• Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience.

  Gironés R, Torregrosa D, Díaz-Beveridge R. Gironés R, et al. Crit Rev Oncol Hematol. 2010 Mar;73(3):236-45. doi: 10.1016/j.critrevonc.2009.08.002. Epub 2009 Sep 12. Crit Rev Oncol Hematol. 2010. PMID: 19748793

• Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.

  Orsitto G, Cascavilla L, Franceschi M, Aloia RM, Greco A, Paris F, Seripa D, Pilotto A. Orsitto G, et al. J Nutr Health Aging. 2005;9(3):194-8. J Nutr Health Aging. 2005. PMID: 15864400

• The application of the principles of geriatrics to the management of the older person with cancer.

  Balducci L, Beghe C. Balducci L, et al. Crit Rev Oncol Hematol. 2000 Sep;35(3):147-54. doi: 10.1016/s1040-8428(00)00089-5. Crit Rev Oncol Hematol. 2000. PMID: 10960797 Review.

• Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients.

  Chaïbi P, Magné N, Breton S, Chebib A, Watson S, Duron JJ, Hannoun L, Lefranc JP, Piette F, Menegaux F, Spano JP. Chaïbi P, et al. Crit Rev Oncol Hematol. 2011 Sep;79(3):302-7. doi: 10.1016/j.critrevonc.2010.08.004. Epub 2010 Dec 15. Crit Rev Oncol Hematol. 2011. PMID: 20888781 Review.

• Surgery offers survival advantage over radiotherapy in patients who are 80 years and older with Stage I and II NSCLC: A retrospective cohort study of 7,045 patients.

  Guo Q, Hu S, Ye J, Su L, Wang S, Zhang D, Zhang Y, Qiu S, Zhu L, Ruan L, Wan B, Zou S, Zhang W, Yu D, Xu J, Zhang H, Wei Y. Guo Q, et al. Front Surg. 2022 Oct 4;9:1018320. doi: 10.3389/fsurg.2022.1018320. eCollection 2022. Front Surg. 2022. PMID: 36268213 Free PMC article.

• The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care.

  Chou WC, Kao CY, Wang PN, Chang H, Wang HM, Chang PH, Yeh KY, Hung YS. Chou WC, et al. BMC Palliat Care. 2015 Apr 30;14:18. doi: 10.1186/s12904-015-0011-5. BMC Palliat Care. 2015. PMID: 25924723 Free PMC article.

• Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

  Wallwiener CW, Hartkopf AD, Grabe E, Wallwiener M, Taran FA, Fehm T, Brucker SY, Krämer B. Wallwiener CW, et al. J Cancer Res Clin Oncol. 2016 Aug;142(8):1847-53. doi: 10.1007/s00432-016-2194-4. Epub 2016 Jun 27. J Cancer Res Clin Oncol. 2016. PMID: 27350260

• Management of elderly patients.

  Vergnenegre A, Corre R, Lena H, Le Caer H. Vergnenegre A, et al. Transl Lung Cancer Res. 2013 Jun;2(3):200-7. doi: 10.3978/j.issn.2218-6751.2013.02.04. Transl Lung Cancer Res. 2013. PMID: 25806233 Free PMC article. Review.

• A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.

  Shouse G, Kaempf A, Gordon MJ, Artz A, Yashar D, Sigmund AM, Smilnak G, Bair SM, Mian A, Fitzgerald LA, Bajwa A, Jaglowski S, Bailey N, Shadman M, Patel K, Stephens DM, Kamdar M, Hill BT, Gauthier J, Karmali R, Nastoupil LJ, Kittai AS, Danilov AV. Shouse G, et al. Blood Adv. 2023 Jul 25;7(14):3516-3529. doi: 10.1182/bloodadvances.2022009309. Blood Adv. 2023. PMID: 36735393 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3